139 related articles for article (PubMed ID: 10432669)
1. "Mixed inhibitors" of HIV-reverse transcriptase: synthesis and antiviral activity.
Pontikis R; Note R; Dechaux E; Guillaumel J; Aubertin AM; Grierson DS; Monneret C
Nucleosides Nucleotides; 1999; 18(4-5):707-8. PubMed ID: 10432669
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
Pontikis R; Dollé V; Guillaumel J; Dechaux E; Note R; Nguyen CH; Legraverend M; Bisagni E; Aubertin AM; Grierson DS; Monneret C
J Med Chem; 2000 May; 43(10):1927-39. PubMed ID: 10821705
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
4. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
[TBL] [Abstract][Full Text] [Related]
6. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors.
Ma XD; He QQ; Zhang X; Yang SQ; Yang LM; Gu SX; Zheng YT; Chen FE; Dai HF
Eur J Med Chem; 2012 Dec; 58():504-12. PubMed ID: 23164656
[TBL] [Abstract][Full Text] [Related]
10. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
Li D; Zhan P; De Clercq E; Liu X
J Med Chem; 2012 Apr; 55(8):3595-613. PubMed ID: 22268494
[No Abstract] [Full Text] [Related]
11. Investigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors.
Thomas MG; Maga G; Mouscadet JF; Howarth NM
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1063-6. PubMed ID: 18058537
[TBL] [Abstract][Full Text] [Related]
12. Development of nonnucleoside HIV reverse transcriptase inhibitors.
Tucker TJ; Lumma WC; Culberson JC
Methods Enzymol; 1996; 275():440-72. PubMed ID: 9026654
[No Abstract] [Full Text] [Related]
13. Design, synthesis, in vitro and in silico studies of novel 4-oxoquinoline ribonucleoside derivatives as HIV-1 reverse transcriptase inhibitors.
Forezi LDSM; Ribeiro MMJ; Marttorelli A; Abrantes JL; Rodrigues CR; Castro HC; Souza TML; Boechat FDCS; de Souza AMT; de Souza MCBV
Eur J Med Chem; 2020 May; 194():112255. PubMed ID: 32244098
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological properties and anti-HIV-1 activity of new pyrimidine P1,P2-dinucleotides.
Miazga A; Ziemkowski P; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):438-44. PubMed ID: 20544533
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
[TBL] [Abstract][Full Text] [Related]
16. Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.
Frączek T; Kamiński R; Krakowiak A; Naessens E; Verhasselt B; Paneth P
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):9-16. PubMed ID: 29098886
[TBL] [Abstract][Full Text] [Related]
17. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Anti-HIV-1 Evaluation of Some Novel MC-1220 Analogs as Non-Nucleoside Reverse Transcriptase Inhibitors.
Loksha YM; Pedersen EB; Loddo R; La Colla P
Arch Pharm (Weinheim); 2016 May; 349(5):363-72. PubMed ID: 26996241
[TBL] [Abstract][Full Text] [Related]
19. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Farmaco; 2004 Jan; 59(1):33-9. PubMed ID: 14751314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
